You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: inadequate data exist on prevention and treatment strategies for foot ulcer in diabetes mellitus

https://doi.org/10.1136/ebm.5.4.117

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (1999) Diabet Med 16, 801; Mason J, O'Keeffe C, McIntosh A, et al. . A systematic review of foot ulcer in patients with type 2 diabetes mellitus. I: Prevention. . . Oct;. :. –12..
    OpenUrlCrossRefPubMedWeb of Science
    (1999) Diabet Med 16, 889. Mason J, O'Keeffe C, Hutchinson A. , et al. . A systematic review of foot ulcer in patients with type 2 diabetes mellitus. II: Treatment. . . Nov;. :. –909..
    OpenUrlCrossRefPubMedWeb of Science

    
 
 QUESTION: What strategies are effective in the prevention and treatment of foot ulcer in patients with diabetes mellitus?

    Data sources

    Studies from 1983 to 1998 were identified from the Cochrane Trials Register, Medline, EMBASE/Excerpta Medica, CINAHL, HealthStar, PsycLIT, Science Citation Index, Social Science Citation Index, Index to Scientific and Technical Conference Proceedings, the HMIC database, and SIGLE.

    Study selection

    Studies were selected if they concerned screening, management, prevention, or education relating to the foot care of people with type 1 or type 2 diabetes.

    Data extraction

    Data were extracted on study design, interventions, and outcomes.

    Main results

    In relation to the prevention of diabetic foot ulcer, the search identified 5 randomised controlled trials (RCTs) of shared care by specialists and general practitioners, care by a hospital diabetes clinic, and care by general practitioners for patients without foot complications; 6 RCTs of foot care education (foot hygiene, treatment …

    View Full Text

    Footnotes

    • Sources of funding: NHS Executive and the British Diabetic Association.

    • For correspondence: Dr J Mason, Medicines Evaluation Group, Centre for Health Economics, University of York, Heslington, York YO1 5DD, UK. Fax +44 (0)1904 433644.